Skip to content

Nasdaq · CIK 0001835597

PEPG PepGen Inc.

Insider trading from SEC Form 4. Last filing Dec 18, 2025. Close $2.62 on Oct 9, 2026, +94% from the 52-week low and -63% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company

Price and insider trades, last year

PEPGOct 9, 2026 · close 2.62

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at PepGen Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
53ModerateRa Capital Management, L.p.
director, owner
buy
$30M
9,375,000 shares
+102%+407% from low-48% from high
29WeakPaul Streck
EVP, Head of R&D
buy
$10k
8,375 shares
+43%+46% from low-85% from high
41ModerateJames G McArthur
President and CEO
buy
$14k
10,000 shares
+10%+33% from low-86% from high
60NotableJames G McArthur
President and CEO
buy
$48k
41,500 shares
+66%0% from low-90% from high
13WeakMary Beth DeLena
General Counsel
sell
$2,406
1,432 shares
-48%-
20WeakNoel Donnelly
Chief Financial Officer
sell
$2,565
1,527 shares
-48%-

Transactions

The last 29 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Nov 4, 2025Noel Donnelly
Chief Financial Officer
DDisposition to issuer
Stock Option (Right to Buy)derivative
-203,339$0.00$00Dec 18, 2025
Nov 4, 2025Noel Donnelly
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+203,339$0.00$0203,339Dec 18, 2025
Nov 4, 2025Noel Donnelly
Chief Financial Officer
DDisposition to issuer
Stock Option (Right to Buy)derivative
-169,037$0.00$00Dec 18, 2025
Nov 4, 2025Noel Donnelly
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+169,037$0.00$0169,037Dec 18, 2025
Nov 4, 2025Noel Donnelly
Chief Financial Officer
DDisposition to issuer
Stock Option (Right to Buy)derivative
-144,000$0.00$00Dec 18, 2025
Nov 4, 2025Noel Donnelly
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+144,000$0.00$0144,000Dec 18, 2025
Nov 4, 2025Noel Donnelly
Chief Financial Officer
DDisposition to issuer
Stock Option (Right to Buy)derivative
-144,000$0.00$00Dec 18, 2025
Nov 4, 2025Noel Donnelly
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+144,000$0.00$0144,000Dec 18, 2025
Sep 26, 2025Ra Capital Management, L.p.
director, owner
POpen-market purchase
Common Stockindirect: See footnotes
+9,375,000$3.20$30M18,554,273Sep 30, 2025
Jun 4, 2025Joshua Resnick
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,000$0.00$016,000Jun 6, 2025
Jun 4, 2025Howard Mayer
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,000$0.00$016,000Jun 6, 2025
Jun 4, 2025Ra Capital Management, L.p.
director, owner
AGrant or award
Stock Option (Right to Buy)derivativeindirect: See Footnotes
+16,000$0.00$016,000Jun 6, 2025
Jun 4, 2025Heidi Henson
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,000$0.00$016,000Jun 6, 2025
Jun 4, 2025Habib J Dable
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,000$0.00$016,000Jun 6, 2025
Jun 4, 2025Laurie Keating
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,000$0.00$016,000Jun 6, 2025
May 30, 2025Paul Streck
EVP, Head of R&D
POpen-market purchase
Common Stock
+8,375$1.24$10k27,805Jun 2, 2025
May 20, 2025Kasra Kasraian
Chief Technical Officer
AGrant or award
Common Stock
+16,750$0.00$016,750May 21, 2025
May 20, 2025Kasra Kasraian
Chief Technical Officer
AGrant or award
Stock Option (Right to Buy)derivative
+75,000$0.00$075,000May 21, 2025
Apr 17, 2025James G McArthur
President and CEO
POpen-market purchase
Common Stock
+10,000$1.36$14k113,913Apr 22, 2025
Apr 8, 2025James G McArthur
President and CEO
POpen-market purchase
Common Stock
+41,500$1.15$48k103,913Apr 9, 2025
Mar 27, 2025Mitchell H. Finer
director
AGrant or award
Stock Option (Right to Buy)derivative
+26,000$0.00$026,000Mar 31, 2025
Mar 3, 2025Mary Beth DeLena
General Counsel
AGrant or award
Common Stock
+13,400$0.00$014,968Mar 5, 2025
Mar 3, 2025Noel Donnelly
Chief Financial Officer
AGrant or award
Common Stock
+23,283$0.00$024,956Mar 5, 2025
Mar 3, 2025Mary Beth DeLena
General Counsel
AGrant or award
Stock Option (Right to Buy)derivative
+60,000$0.00$060,000Mar 5, 2025
Mar 3, 2025Noel Donnelly
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+104,250$0.00$0104,250Mar 5, 2025
Feb 24, 2025Mary Beth DeLena
General Counsel
AGrant or award
Common Stock
+3,000$0.00$03,000Feb 26, 2025
Feb 24, 2025Noel Donnelly
Chief Financial Officer
AGrant or award
Common Stock
+3,200$0.00$03,200Feb 26, 2025
Feb 26, 2025Mary Beth DeLena
General Counsel
SOpen-market sale
Common Stock10b5-1
-1,432$1.68$2,4061,568Feb 26, 2025
Feb 26, 2025Noel Donnelly
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-1,527$1.68$2,5651,673Feb 26, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

PEPG insider trading: PepGen Inc. | InsiderTell